# An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment

> **NCT03266003** · NA · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 216 (actual)

## Conditions studied

- Tuberculosis
- Drug-resistant Tuberculosis
- Adherence, Medication
- Adherence, Patient

## Interventions

- **OTHER:** Electronic DOT
- **OTHER:** In-person DOT

## Key facts

- **NCT ID:** NCT03266003
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-19
- **Primary completion:** 2020-01-10
- **Final completion:** 2020-12-31
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03266003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03266003, "An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03266003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*